Posts for Universe Pharmaceuticals INC ($UPC)

Explore Universe Pharmaceuticals' February 2025 Form 6-K detailing an indefinite adjournment of the extraordinary general meeting. Key insights on governance and decision-making.

Explore Universe Pharmaceuticals INC's Form 6-K report detailing the adjournment of the February 2025 extraordinary general meeting and compliance with SEC regulations.

Explore Universe Pharmaceuticals Inc.'s 6-K report detailing the February 2025 shareholder meeting agenda, including revised share consolidation proposals and important notices.